Self-adjuvanting vaccine against group A streptococcus: Application of fibrillized peptide and immunostimulatory lipid as adjuvant

Bioorganic and Medicinal Chemistry

Volumn 22, Issue 22, 2014, Pages 6401-6408

  Azmi, Fazren ^a,b   Ahmad Fuaad, Abdullah Al Hadi ^a   Giddam, Ashwini Kumar ^a   Batzloff, Michael R ^c   Good, Michael F ^c   Skwarczynski, Mariusz ^a   Toth, Istvan ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^c GRIFFITH UNIVERSITY   (Australia)

Author keywords

Delivery; Fibril; Group A streptococcus; Lipopeptide; Peptide; Vaccine

Indexed keywords

EPITOPE; GLUTAMINYLGLUTAMINYLLYSYLPHENYLALANYLGLUTAMINYLPHENYLALANYLGLUTAMINYLPHENYLALANYLGLUTAMYLGLUTAMINYLGLUTAMINE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOLOGICAL ADJUVANT; LIPOAMINO ACID; LYSYLGLUTAMINYLALANYLGLUTAMYLASPARTYLLYSYLVALYLLYSYLALANYLSERYLARGINYLGLUTAMYLALANYLLYSYLLYSYLGLUTAMINYLVALYLGLUTAMYLLYSYLALANYLLEUCYLGLUTAMYLGLUTAMINYLLEUCYLGLTAMYLASPARTYLLYSYLVALYLLYSINE VACCINE; M PROTEIN; NANOPARTICLE; PEPTIDE VACCINE; STREPTOCOCCUS VACCINE; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; IMMUNOGLOBULIN G; LIPOPEPTIDE; RECOMBINANT VACCINE;

ALPHA HELIX; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; CELL TRANSPORT; CIRCULAR DICHROISM; CONTROLLED STUDY; CROSS REACTION; DENDRITIC CELL; DRUG CONJUGATION; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; HUMORAL IMMUNITY; IMMUNOGENICITY; IMMUNOMODULATION; LIGHT SCATTERING; MACROPHAGE; MOUSE; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PROTEIN ASSEMBLY; PROTEIN CONFORMATION; PROTEIN FOLDING; STREPTOCOCCUS GROUP A; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; STREPTOCOCCUS PYOGENES;

ADJUVANTS, IMMUNOLOGIC; AMINO ACID SEQUENCE; ANIMALS; BACTERIAL PROTEINS; CIRCULAR DICHROISM; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; IMMUNOGLOBULIN G; LIPOPEPTIDES; MACROPHAGES; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; MOLECULAR SEQUENCE DATA; STREPTOCOCCUS PYOGENES; VACCINES, SYNTHETIC;

EID: 84908377070     PISSN: 09680896     EISSN: 14643391     Source Type: Journal    
DOI: 10.1016/j.bmc.2014.09.042     Document Type: Article

References (41)

1. F. Azmi, A.A.H. Ahmad Fuaad, M. Skwarczynski, and I. Toth Hum. Vaccines Immunother. 10 2013 778
2. M. Skwarczynski, and I. Toth Curr. Drug Deliv. 8 2011 282
3. H. Gras-Masse Mol. Immunol. 38 2001 423
4. C. Olive, M. Batzloff, A. Horvath, T. Clair, P. Yarwood, I. Toth, and M.F. Good Infect. Immun. 71 2003 2373
5. Skwarczynski, M.; Toth, I. In Bioconjugation Protocols: Strategies and Methods, 2nd ed.; Mark, S. S., Ed.; 2011; Vol. 751, pp. 297.
6. W. Zeng, S. Ghosh, Y.F. Lau, L.E. Brown, and D.C. Jackson J. Immunol. 169 2002 4905
7. J.S. Rudra, Y.F. Tian, J.P. Jung, and J.H. Collier Proc. Natl. Acad. Sci. U.S.A. 107 2010 622
8. J.S. Rudra, S. Mishra, A.S. Chong, R.A. Mitchell, E.H. Nardin, V. Nussenzweig, and J.H. Collier Biomaterials 33 2012 6476
9. J.J. Chen, R.R. Pompano, F.W. Santiago, L. Maillat, R. Sciammas, T. Sun, H.F. Han, D.J. Topham, A.S. Chong, and J.H. Collier Biomaterials 34 2013 8776
10. M. Zaman, A.B. Abdel-Aal, Y. Fujita, K.S. Phillipps, M.R. Batzloff, M.F. Good, and I. Toth PloS One 7 2012 e30146
11. M. Skwarczynski, A.M. Dougall, M. Khoshnejad, S. Chandrudu, M.S. Pearson, A. Loukas, and I. Toth PloS One 7 2012 e46870
12. W. Zhong, M. Skwarczynski, Y. Fujita, P. Simerska, M.F. Good, and I. Toth Aust. J. Chem. 62 2009 993
13. C. Olive, H.K. Sun, M.F. Ho, J. Dyer, A. Horvath, I. Toth, and M.F. Good J. Infect. Dis. 194 2006 316
14. C. Olive, K. Schulze, H.K. Sun, T. Ebensen, A. Horvath, I. Toth, and C.A. Guzman Vaccine 25 2007 1789
15. A.B.M. Abdel-Aal, K. Al-Isae, M. Zaman, and I. Toth Bioorg. Med. Chem. Lett. 21 2011 5863
16. A.B.M. Abdel-Aal, D. El-Naggar, M. Zaman, M. Batzloff, and I. Toth J. Med. Chem. 55 2012 6968
17. W.A. Relf, J. Cooper, E.R. Brandt, W.A. Hayman, R.F. Anders, S. Pruksakorn, B. Currie, A. Saul, and M.F. Good Peptide Res. 9 1996 12
18. S. Pruksakorn, B. Currie, E. Brandt, C. Phornphutkul, S. Hunsakunachai, A. Manmontri, J.H. Robinson, M.A. Kehoe, A. Galbraith, and M.F. Good Int. Immunol. 6 1994 1235
19. H. Vohra, N. Dey, S. Gupta, A.K. Sharma, R. Kumar, D. McMillan, and M.F. Good Res. Microbiol. 156 2005 575
20. W.A. Hayman, E.R. Brandt, W.A. Relf, J. Cooper, A. Saul, and M.F. Good Int. Immunol. 9 1997 1723
21. A.A.H.A. Fuaad, Z.F. Jia, M. Zaman, J. Hartas, Z.M. Ziora, I.C. Lin, P.M. Moyle, M.R. Batzloff, M.F. Good, M.J. Monteiro, M. Skwarczynski, and I. Toth Nanomedicine (UK) 9 2014 35
22. M. Skwarczynski, M. Zaman, C.N. Urbani, I.C. Lin, Z.F. Jia, M.R. Batzloff, M.F. Good, M.F. Monteiro, and I. Toth Angew. Chem. Int. Ed. 49 2010 5742
23. M. Zaman, A.B. Abdel-Aal, Y. Fujita, Z.M. Ziora, M.R. Batzloff, M.F. Good, and I. Toth J. Med. Chem. 55 2012 8515
24. M. Black, A. Trent, M. Tirrell, and C. Olive Expert Rev. Vaccines 9 2010 157
25. R.P.J. Lai, M.S. Seaman, P. Tonks, F. Wegmann, D.J. Seilly, S.D.W. Frost, C.C. LaBranche, D.C. Montefiori, A.K. Dey, I.K. Srivastava, Q. Sattentau, S.W. Barnett, and J.L. Heeney PloS One 7 2012 e35083
26. T.Y. Liu, W.M. Hussein, I. Toth, and M. Skwarczynski Curr. Top. Med. Chem. 12 2012 1581
27. M. Schnolzer, P. Alewood, A. Jones, D. Alewood, and S.B.H. Kent Int. J. Pept. Res. Ther. 13 2007 31
28. J. Metzger, K.H. Wiesmuller, R. Schaude, W.G. Bessler, and G. Jung Int. J. Pept. Protein Res. 37 1991 46
29. W.G. Zeng, S. Ghosh, Y.F. Lau, L.E. Brown, and D.C. Jackson J. Immunol. 169 2002 4905
30. M. Zaman, A.M. Abdel-Aal, K.S.M. Phillipps, Y. Fujita, M.F. Good, and I. Toth Vaccine 28 2010 2243
31. J.H. Collier, and P.B. Messersmith Bioconjugate Chem. 14 2003 748
32. M. Skwarczynski, K.A. Kamaruzaman, S. Srinivasan, M. Zaman, I.C. Lin, M.R. Batzloff, M.F. Good, and I. Toth Curr. Drug Deliv. 10 2013 39
33. M. Skwarczynski, B.H. Parhiz, F. Soltani, S. Srinivasan, K.A. Kamaruzaman, I.C. Lin, and I. Toth Aust. J. Chem. 65 2012 35
34. M. Skwarczynski, A.A. Ahmad Fuaad, L. Rustanti, Z.M. Ziora, M. Aqil, M. Batzloff, M. Good, and I. Toth Drug Deliv. Lett. 1 2011 2 8
35. L. BenMohamed, S.L. Wechsler, and A.B. Nesburn Lancet Infect. Dis. 2 2002 425
36. Z.M. Ziora, M.A. Blaskovich, I. Toth, and M.A. Cooper Curr. Top. Med. Chem. 12 2012 1562
37. J.S. Rudra, T. Sun, K.C. Bird, M.D. Daniels, J.Z. Gasiorowski, A.S. Chong, and J.H. Collier ACS Nano 6 2012 1557
38. S.D. Xiang, A. Scholzen, G. Minigo, C. David, V. Apostolopoulos, P.L. Mottram, and M. Plebanski Methods 40 2006 1
39. K.S.M. Phillipps, M.N. Wykes, X.Q. Liu, M. Brown, J. Blanchfield, and I. Toth Immunology 128 2009 e582
40. P.M. Moyle, J. Hartas, A. Henningham, M.R. Batzloff, M.F. Good, and I. Toth Nanomed.-Nanotechnol. 9 2013 935
41. A.B.M. Abdel-Aal, M.R. Batzloff, Y. Fujita, N. Barozzi, A. Faria, P. Simerska, P.M. Moyle, M.F. Good, and I. Toth J. Med. Chem. 51 2008 167